| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | | | | |
|
PR:000046650 | T-lymphocyte activation antigen CD80, signal peptide removed form (human) | | | | | |
| | | | |
|
PR:P33681 | T-lymphocyte activation antigen CD80 (human) | | | | | |
| | | | | |
|
PR:P33681-1 | T-lymphocyte activation antigen CD80 isoform h1 (human) | | | | | |
| | | | | |
|
PR:P33681-2 | T-lymphocyte activation antigen CD80 isoform h2 (human) | | | | | |
| | | | | |
|
PR:P33681-3 | T-lymphocyte activation antigen CD80 isoform h3 (human) | | | | | |
| | | | | |
|
PR:000046650 | T-lymphocyte activation antigen CD80, signal peptide removed form (human) | | | | | |
| | | | |
|
PR:Q00609 | T-lymphocyte activation antigen CD80 (mouse) | | | | | |
| | | | | |
|
PR:Q00609-1 | T-lymphocyte activation antigen CD80 isoform m1 (mouse) | | | | | |
| | | | | |
|
PR:Q00609-2 | T-lymphocyte activation antigen CD80 isoform m2 (mouse) | | | | | |
| |
| | | | |
|
PR:P42081 | T-lymphocyte activation antigen CD86 (human) | | | | | |
| | | | | |
|
PR:P42081-1 | T-lymphocyte activation antigen CD86 isoform h1 (human) | | | | | |
| | | | | |
|
PR:P42081-3 | T-lymphocyte activation antigen CD86 isoform h2 (human) | | | | | |
| | | | | |
|
PR:P42081-2 | T-lymphocyte activation antigen CD86 isoform h3 (human) | | | | | |
| | | | | |
|
PR:P42081-4 | T-lymphocyte activation antigen CD86 isoform h4 (human) | | | | | |
| | | | | |
|
PR:P42081-5 | T-lymphocyte activation antigen CD86 isoform h5 (human) | | | | | |
| | | | | |
|
PR:P42081-6 | T-lymphocyte activation antigen CD86 isoform h6 (human) | | | | | |
| | | | | |
|
PR:000046652 | T-lymphocyte activation antigen CD86, signal peptide removed form (human) | | | | | |
| | | | |
|
PR:P42082 | T-lymphocyte activation antigen CD86 (mouse) | | | | | |
| | | | | |
|
PR:P42082-1 | T-lymphocyte activation antigen CD86 isoform m1 (mouse) | | | | | |
| | | | | |
|
PR:P42082-2 | T-lymphocyte activation antigen CD86 isoform m2 (mouse) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| | | | | |
|
PR:000047939 | ICOS ligand, signal peptide removed form (human) | | | | | |
| |
| |
| |
| |
| | | | |
|
PR:Q9NZQ7 | programmed cell death 1 ligand 1 (human) | | | | | |
| | | | | |
|
PR:000078498 | programmed cell death 1 ligand 1 deaminated 1 (human) | | | | | |
| | | | | |
|
PR:Q9NZQ7-1 | programmed cell death 1 ligand 1 isoform h1 (human) | | | | | |
| | | | | |
|
PR:Q9NZQ7-2 | programmed cell death 1 ligand 1 isoform h2 (human) | | | | | |
| | | | | |
|
PR:Q9NZQ7-3 | programmed cell death 1 ligand 1 isoform h3 (human) | | | | | |
| | | | | |
|
PR:Q9NZQ7-4 | programmed cell death 1 ligand 1 isoform h4 (human) | | | | | |
| | | | | |
|
PR:000046626 | programmed cell death 1 ligand 1, signal peptide removed form (human) | | | | | |
| | | | |
|
PR:Q9EP73 | programmed cell death 1 ligand 1 (mouse) | | | | | |
| |
| | | | |
|
PR:Q9BQ51 | programmed cell death 1 ligand 2 (human) | | | | | |
| | | | | |
|
PR:000071332 | programmed cell death 1 ligand 2 deaminated 1 (human) | | | | | |
| | | | | |
|
PR:Q9BQ51-1 | programmed cell death 1 ligand 2 isoform h1 (human) | | | | | |
| | | | | |
|
PR:Q9BQ51-2 | programmed cell death 1 ligand 2 isoform h2 (human) | | | | | |
| | | | | |
|
PR:Q9BQ51-3 | programmed cell death 1 ligand 2 isoform h3 (human) | | | | | |
| | | | | |
|
PR:000048714 | programmed cell death 1 ligand 2, signal peptide removed form (human) | | | | | |
| | | | |
|
PR:Q9WUL5 | programmed cell death 1 ligand 2 (mouse) | | | | | |
| | | | |
|
PR:000018512 | programmed cell death 1 ligand 2, signal peptide removed form | | | | | |
| | | | | |
|
PR:000048714 | programmed cell death 1 ligand 2, signal peptide removed form (human) | | | | | |